Go Ad-Free
My Alerts
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
VICTORIS
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
MARKETS

Alembic Pharmaceuticals Ltd.

BSE: 533573 | NSE: APLLTD |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE901L01018 | SECTOR: Pharmaceuticals & Drugs

| BSE 798.80 2.80 (0.35%) | |

BSE Live

Feb 10, 14:01
798.80 2.80 (0.35%)
Volume
AVERAGE VOLUME
5-Day
6,902
10-Day
4,503
30-Day
3,867
1,810

  • Prev. Close

    796.00

  • Open Price

    796.30

  • Bid Price (Qty.)

    798.95 (20)

  • Offer Price (Qty.)

    800.70 (10)

NSE Live

Feb 10, 14:01
800.40 4.45 (0.56%)
Volume
AVERAGE VOLUME
5-Day
97,423
10-Day
67,108
30-Day
59,284
13,829

  • Prev. Close

    795.95

  • Open Price

    799.95

  • Bid Price (Qty.)

    799.40 (15)

  • Offer Price (Qty.)

    800.25 (4)

Financials

Cash Flow of Alembic Pharmaceuticals (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 707.18 631.83 354.59 620.11 1,368.08  
Net CashFlow From Operating Activities 87.97 803.20 723.95 552.36 1,463.38  
Net Cash Used In Investing Activities -568.41 -320.61 -447.59 -371.97 -838.81  
Net Cash Used From Financing Activities 443.71 -437.86 -261.96 -217.36 -597.42  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 -0.93  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -36.73 44.73 14.40 -36.97 26.22  
Cash And Cash Equivalents Begin of Year 120.21 75.48 61.08 98.06 71.84  
Cash And Cash Equivalents End Of Year 83.48 120.21 75.48 61.09 98.06  
Source : Dion Global Solutions Limited

Results of Alembic Pharma

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026